Prevalencia de la fibrilación auricular desconocida y la no tratada con anticoagulantes. Estudio AFABE

Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of six population-based studies. DARIOS Study

“…These results are greater than in other studies that have reported percentages of patients on treatment to be greater than 50%, 31,33 but they do agree with those recently published by FIATE 34 and AFABE. 35 Previous studies have shown that, in addition to age, AF is associated with the male sex, 7,10 hypertension, 5,7,36 CVD 36 and obesity. 37 However, we found no significant association with DM, as reported in previous studies, 7,10,14 nor with hypercholesterolemia, which agrees with Iguchi et al 10 In terms of the study strengths, the DARIOS study included 11 studies in population-based randomized samples, performed during the first decade of the 21th century.…”

Complex Chronic Patients and Atrial Fibrillation: Association with Cognitive Deterioration and Heart Failure

“…In the present study, we observed that 70% of the patients with cognitive deterioration had a TTR of <60%, as well as 60% of patients with heart failure. This way, cognitive decline associated with poor results in TTR again suggests that there may be a relationship between the two conditions [31,32].…”

“…According to the clinical guidelines, if the time in therapeutic range (TTR) cannot be maintained at ≥60% with the use of anti-vitamin K, the use of new oral anticoagulants (NOACs) should be taken into consideration [1]. Internationally, qualitative studies on the treatment with anti-vitamin K have shown poor results in the general practice and untreated patients are associated with atrial fibrillation burden, chronicity, and comorbidity for adverse outcomes [7,[30][31]. In the present study, we observed that 70% of the patients with cognitive deterioration had a TTR of <60%, as well as 60% of patients with heart failure.…”

Prevalencia de fibrilación auricular y factores asociados en España, análisis de seis estudios de base poblacional. Estudio DARIOS

“…En nuestro estudio casi 3 de 4 individuos estaban en tratamiento con ACO, aunque los datos recogidos no permiten establecer su riesgo embólico previo con el uso de la escala referida. Estos resultados son mayores que en otros estudios que han comunicado porcentuales de pacientes bajo tratamiento superiores al 50% 31,33 pero sí se encuentra en coincidencia con los recientemente publicados FIATE 34 y AFABE 35 .…”